Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order

Accesswire July 9, 2024

StageZero Life Sciences Announces Update on Filing of Full Year 2023 financials under the Failure to File Cease Trade Order

Accesswire July 3, 2024

StageZero Life Sciences Announces Update on Failure to File Cease Trade Order

Accesswire May 23, 2024

StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update

Accesswire May 17, 2024

Canadian Investment Regulatory Organization Trading Halt - SZLS

Canada NewsWire April 9, 2024

StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order

Accesswire April 5, 2024

StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results

Accesswire April 2, 2024

StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update

Accesswire November 15, 2023

StageZero Life Sciences and My One Medical Source collaborate

Jocelyn Aspa November 14, 2023

StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA

Accesswire November 14, 2023

StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings

Accesswire November 7, 2023

StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings

Accesswire October 20, 2023

StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Newsfile June 20, 2023

StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

Newsfile June 7, 2023

StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Newsfile June 5, 2023

StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update

Newsfile May 16, 2023

StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

Newsfile May 15, 2023

StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

Newsfile March 31, 2023

Anatomy of a Flagship Asset: StageZero Life Sciences' (TSX:SZLS) pre-symptom cancer detection

Trevor Abes  March 31, 2023

StageZero to Issue Q4 2022 Financial Results on Friday March 31

Newsfile March 30, 2023